Working… Menu

Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01817192
Recruitment Status : Recruiting
First Posted : March 25, 2013
Last Update Posted : September 21, 2021
Encore Clinical
Information provided by (Responsible Party):
Encore Clinical ( Razor Genomics )